Meet Our Team

Until the ISEO becomes a legal entity with bylaws and a constitution, the leadership of the organization are appointed. This is expected to change as the organization matures. Here are the stalwarts who have driven the genesis of ISEO.

Dr Kathryn Schmitz
Dr Kathryn SchmitzFounder
The ISEO founder, Dr. Kathryn Schmitz, is an exercise oncology researcher at the University of Pittsburgh. She is a former president of the American College of Sports Medicine and first author of the first ACSM Exercise and Cancer Roundtable document from 2010. Her research on lymphedema and exercise changed clinical practice for breast cancer patients. She is also the founder of the Moving Through Cancer initiative, which has a bold goal of making exercise standard of care by 2029. She is also the receipient of an American Cancer Society Clinical Research Professorship award. Dr. Schmitz is committed to continuing organizing ISEO until such time that elections can be held.
Prof Kerry Courneya
Prof Kerry CourneyaFounding Member
Professor and Canada Research Chair in Physical Activity and Cancer and Director of the Exercise Oncology Research Laboratory at the University of Alberta in Edmonton, Canada. Research program focuses on the role of exercise after a cancer diagnosis (i.e., exercise oncology) including how exercise may help cancer patients prepare for treatments (prehablitation), tolerate and respond to treatments, recover after treatments (rehabilitation), and improve long-term survival.
Prof Rob Newton AM
Prof Rob Newton AMFounding Member
Professor of Exercise Medicine in the Exercise Medicine Research Institute that he established in 2004 at Edith Cowan University, Perth, Western Australia. Current major research directions include: exercise medicine as neoadjuvant, adjuvant and rehabilitative cancer therapy to reduce side-effects and enhance effectiveness of surgery, chemotherapy and radiation therapy; the influence of targeted exercise medicine on tumour biology and exercise medicine for reducing decline in quality of life, strength, body composition and functional ability in patients with cancer.
Dr Allison Betof Warner
Dr Allison Betof WarnerFounding Member
Dr. Betof Warner is a board-certified, fellowship-trained medical oncologist with the Cutaneous Oncology Program and an Assistant Professor in the Department of Medicine, Division of Medical Oncology. She also serves as Director of Melanoma Medical Oncology, Director of Solid Tumor Cellular Therapy, and co-Director of the Pigmented Lesion and Melanoma Program.

Clinical interests of Dr. Betof Warner include treatment of advanced melanoma, immunotherapy, and cellular therapies for solid tumors. She has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy, which is expected to become standard of care for immunotherapy-refractory melanoma.

Dr Ann May
Dr Ann MayFounding Member
Anne works as a professor of clinical epidemiology of cancer survivorship and director of research at the Julius Center, University Medical Center Utrecht, the Netherlands. She combines this with working as a group leader for the Lifestyle and Cancer Survivorship Care research group at the Netherlands Cancer Institute in Amsterdam. Starting during her PhD research and ever thereafter, she is investigating the effects of exercise on treatment-related side effects and prognosis. She has served at international lifestyle and cancer related guideline panels (ACSM/ASCO/WCRF); and is the PI of several large (inter)national exercise RCTs, e.g., PREFERABLE-EFFECT (https://www.h2020preferable.eu) and PREFERABLE II (https://www.preferable2.eu).
Prof Daniel Galvao
Prof Daniel GalvaoFounding Member
Professor Daniel Galvão is Director of the Exercise Medicine Research Institute at Edith Cowan University, Australia, and Fellow of the American College of Sports Medicine and Exercise and Sports Science Australia. Galvão’s research program developed and tested targeted exercise interventions to reverse treatment-related toxicities and improve patient outcomes that have changed the clinical management of cancer patients worldwide. His research support includes >$25 million in continuing external funding over the past 15 years from the NHMRC, Prostate Cancer Foundation of Australia, Cancer Australia, Cancer Council Western Australia, and Movember Foundation.
Dr Karen Mustian
Dr Karen MustianFounding Member
Dr. Mustian is Dean’s Professor of Surgery and Associate Director of Wilmot Cancer Institute for Population Science. She is the contact MPI and Co-Director for the URCC NCORP Research Base: a nationwide cancer clinical trial network including over 800 oncology practices across the United States funded by the NCI and a member of the NCI Board of Scientific Advisors. Her research focuses developing novel exercise and integrative oncology therapies for alleviating cancer treatment-related toxicities. She has developed multiple ASCO oncology treatment guidelines, published over 175 peer-reviewed papers and is a recipient of the American Society of Clinical Oncology Walther Cancer Foundation Supportive Oncology Award recognizing her lifetime achievements in science to the field of oncology.
Prof Joachim Wiskemann
Prof Joachim WiskemannFounding Member
Dr. Joachim Wiskemann, Ph.D., FACSM, FECSS is a professor in sport science and head of the Exercise Oncology Group at the Heidelberg University Hospital and the National Center for Tumor Diseases (NCT), Heidelberg, Germany. He is member of the ACSM Multidisciplinary Roundtable on Exercise and Cancer Prevention and Control, has substantial experience in exercise programming to cancer patients and has conducted various clinical trials resulting in more than 100 scientific papers. Dr. Wiskemann serves the cancer community by establishing a German-wide exercise oncology network, called OnkoAktiv, as well as a comprehensive exercise care program
Prof Karen Wonders
Prof Karen WondersFounding Member
Founder and CEO of Maple Tree Cancer Alliance, and Professor/Program Director of Exercise Physiology at Wright State University. Her passion is to advocate for exercise as past of the national standard of care for cancer. Through her non-profit organization, Maple Tree provides free exercise training to thousands of cancer survivors every month at dozens of clinical locations across the US. She also has offices internationally in more than 15 countries. An avid researcher, Dr. Wonders is committed to evidence-based practice in her facilities, and has a robust research program with more than 70 peer reviewed manuscripts on the topic of exercise and cancer recovery. Dr. Wonders has given numerous professional presentations on the national, state, and local levels, including a talk at TEDxDayton on Exercising through Cancer Care.

“Exercise is not a single medicine but many different types which can be prescribed at different volume, intensity, and timing to have optimal benefit for the specific health issues the patient is facing.”

Prof ROB NEWTON, RESEARCHER and Clinical Exercise Physiologist

ISEO

We are a dedicated team of health professionals working to improve outcomes for people with cancer.